子宫内膜癌保守治疗后接受辅助生殖技术的患者的不孕治疗结局。
The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer.
作者信息
Fujimoto Akihisa, Ichinose Mari, Harada Miyuki, Hirata Tetsuya, Osuga Yutaka, Fujii Tomoyuki
机构信息
Department of Obstetrics and Gynecology, Sanraku Hospital, 2-5, Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan, 101-8326,
出版信息
J Assist Reprod Genet. 2014 Sep;31(9):1189-94. doi: 10.1007/s10815-014-0297-x. Epub 2014 Aug 10.
Abstract
PURPOSE
To elucidate the problems in infertility treatment for women after conservative therapy for endometrial cancer (EC) or atypical complex endometrial hyperplasia (ACEH).
METHODS
The clinical outcomes of 21 patients who underwent assisted reproductive technology after conservative therapy (group A) and 42 control women (group B) were retrospectively analyzed.
RESULTS
There was no significant difference in the number of retrieved oocytes, fertilization rate or the number of transferred embryos between the two groups. Women in group A had a significantly thinner endometrium and a reduced implantation rate compared to those for women in group B. There was no significant difference in the cumulative clinical pregnancy and delivery rates between group A and B. The patients in group A required significantly more embryos for achieving a live-birth.
CONCLUSIONS
Our results indicate that a thin endometrium after repeated curettage may have a negative effect on endometrial receptivity of patients after conservative treatment for EC/ACEH. Clinicians should reconsider their present protocols and make efforts to minimize the damage to normal endometrium.
摘要
目的
阐明子宫内膜癌（EC）或非典型复杂性子宫内膜增生（ACEH）保守治疗后女性不孕症治疗中的问题。
方法
回顾性分析21例保守治疗后接受辅助生殖技术的患者（A组）和42例对照女性（B组）的临床结局。
结果
两组之间的获卵数、受精率或移植胚胎数无显著差异。与B组女性相比，A组女性的子宫内膜明显更薄，着床率降低。A组和B组之间的累积临床妊娠率和分娩率无显著差异。A组患者需要显著更多的胚胎才能实现活产。
结论
我们的结果表明，反复刮宫后子宫内膜变薄可能对EC/ACEH保守治疗后患者的子宫内膜容受性产生负面影响。临床医生应重新考虑当前方案，并努力将对正常子宫内膜的损伤降至最低。
相似文献
1
The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer.子宫内膜癌保守治疗后接受辅助生殖技术的患者的不孕治疗结局。
J Assist Reprod Genet. 2014 Sep;31(9):1189-94. doi: 10.1007/s10815-014-0297-x. Epub 2014 Aug 10.
2
The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia.不孕治疗对子宫内膜癌和不典型复杂子宫内膜增生预后的影响。
Int J Gynecol Cancer. 2013 Feb;23(2):288-93. doi: 10.1097/IGC.0b013e31827c18a1.
3
4
[Analysis of pregnancy outcome after fertility-preserving treatment among women with atypical endometrial hyperplasia or endometrial carcinoma].非典型子宫内膜增生或子宫内膜癌患者保留生育功能治疗后的妊娠结局分析
Zhonghua Fu Chan Ke Za Zhi. 2020 Dec 25;55(12):857-864. doi: 10.3760/cma.j.cn112141-20200613-00501.
5
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia.接受保留生育功能治疗的高分化子宫内膜癌或非典型子宫内膜增生年轻女性的妊娠结局影响因素。
Reprod Biol Endocrinol. 2016 Jan 15;14:2. doi: 10.1186/s12958-015-0136-7.
6
Current research of Assisted Reproductive Technology for women with early endometrial cancer and atypical endometrial hyperplasia after conservative treatment.早期子宫内膜癌及保守治疗后不典型子宫内膜增生患者行辅助生殖技术的研究现状。
Front Endocrinol (Lausanne). 2024 Jun 11;15:1377396. doi: 10.3389/fendo.2024.1377396. eCollection 2024.
7
Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia.FIGO I级子宫内膜腺癌和/或非典型复杂性增生保守治疗后辅助生殖技术的应用
Gynecol Oncol. 2003 Dec;91(3):569-72. doi: 10.1016/j.ygyno.2003.08.007.
8
Does progesterone-induced endometrial withdrawal bleed before ovulation induction have negative effects on IUI outcomes in patients with polycystic ovary syndrome?在多囊卵巢综合征患者中，排卵诱导前孕酮引起的子宫内膜撤退性出血对宫腔内人工授精结局有负面影响吗？
Int J Clin Exp Pathol. 2013 May 15;6(6):1157-63. Print 2013.
9
National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.生殖年龄段子宫内膜癌或不典型增生女性的护理和生育结局的全国模式。
Am J Obstet Gynecol. 2019 Nov;221(5):474.e1-474.e11. doi: 10.1016/j.ajog.2019.05.029. Epub 2019 May 22.
10
The effect of endometrial injury on ongoing pregnancy rate in unselected subfertile women undergoing in vitro fertilization: a randomized controlled trial.子宫内膜损伤对未选择的接受体外受精的亚生育力女性持续妊娠率的影响：一项随机对照试验。
Hum Reprod. 2014 Nov;29(11):2474-81. doi: 10.1093/humrep/deu213. Epub 2014 Sep 8.
引用本文的文献
1
The value of diffusion-weighted imaging and semi-quantitative dynamic contrast-enhanced MRI in predicting the efficacy of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial carcinoma.扩散加权成像和半定量动态对比增强磁共振成像在预测醋酸甲羟孕酮治疗非典型子宫内膜增生和子宫内膜癌疗效中的价值
BMC Med Imaging. 2025 Jul 1;25(1):210. doi: 10.1186/s12880-025-01754-6.
2
Investigating the Effect of Endometrial Thickness Changes and Compaction on the Fertility Rate of Patients Undergoing ART: A Prospective Study.探讨子宫内膜厚度变化及致密化对接受辅助生殖技术患者生育率的影响：一项前瞻性研究。
J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):198-205. doi: 10.1007/s13224-024-02064-7. Epub 2024 Dec 4.
3
Surgical treatment can provide the opportunity for in-vitro fertilization (IVF) in a shorter period of time for patients with early-stage endometrial cancer.手术治疗可为早期子宫内膜癌患者在更短时间内提供体外受精（IVF）的机会。
Discov Oncol. 2025 Jan 9;16(1):24. doi: 10.1007/s12672-025-01750-w.
4
Current research of Assisted Reproductive Technology for women with early endometrial cancer and atypical endometrial hyperplasia after conservative treatment.早期子宫内膜癌及保守治疗后不典型子宫内膜增生患者行辅助生殖技术的研究现状。
Front Endocrinol (Lausanne). 2024 Jun 11;15:1377396. doi: 10.3389/fendo.2024.1377396. eCollection 2024.
5
Pregnancy outcomes in infertile patients with endometrial hyperplasia with or without atypia undergoing fertilization: the early-follicular long protocol is superior to midluteal long protocol.在接受受精的子宫内膜增生伴或不伴非典型性的不孕患者中，妊娠结局：早卵泡期长方案优于中黄体期长方案。
Front Endocrinol (Lausanne). 2024 Feb 19;15:1314432. doi: 10.3389/fendo.2024.1314432. eCollection 2024.
6
Analysis of risk factors for recurrence in infertile endometrial cancer patients after fertilization treatment.分析不孕子宫内膜癌患者受精治疗后复发的风险因素。
Front Endocrinol (Lausanne). 2023 Nov 22;14:1224622. doi: 10.3389/fendo.2023.1224622. eCollection 2023.
7
Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation?子宫内膜癌的治疗与分子诊断升级——为子宫内膜保护带来新工具？
Int J Mol Sci. 2023 Jun 5;24(11):9780. doi: 10.3390/ijms24119780.
8
Radiotherapy exposure directly damages the uterus and causes pregnancy loss.放疗暴露会直接损伤子宫，导致妊娠丢失。
JCI Insight. 2023 Mar 22;8(6):e163704. doi: 10.1172/jci.insight.163704.
9
Obstetric and perinatal outcomes following frozen and fresh embryo transfer in patients with endometrial hyperplasia and carcinoma: a retrospective study in a high-volume reproductive center.在高容量生殖中心中，对子宫内膜增生和癌患者进行冷冻胚胎移植和新鲜胚胎移植后的产科和围产期结局：一项回顾性研究。
BMC Pregnancy Childbirth. 2023 Feb 3;23(1):92. doi: 10.1186/s12884-023-05418-7.
10
Outcomes after assisted reproductive technology in women with cancer: a systematic review and meta-analysis.癌症女性接受辅助生殖技术后的结局：系统评价和荟萃分析。
Hum Reprod. 2023 Jan 5;38(1):30-45. doi: 10.1093/humrep/deac235.
本文引用的文献
1
Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older.40岁及以上女性辅助生殖技术后成功妊娠的预测因素。
Reprod Med Biol. 2009 Jul 18;8(4):145-149. doi: 10.1007/s12522-009-0023-z. eCollection 2009 Dec.
2
The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia.不孕治疗对子宫内膜癌和不典型复杂子宫内膜增生预后的影响。
Int J Gynecol Cancer. 2013 Feb;23(2):288-93. doi: 10.1097/IGC.0b013e31827c18a1.
3
Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.年轻早期子宫内膜癌患者行保留生育功能治疗后的妊娠结局。
Obstet Gynecol. 2013 Jan;121(1):136-42. doi: 10.1097/aog.0b013e31827a0643.
4
Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis.保留生育功能治疗子宫内膜癌和非典型性复杂子宫内膜增生的复发、缓解和活产率：系统评价和荟萃分析。
Am J Obstet Gynecol. 2012 Oct;207(4):266.e1-12. doi: 10.1016/j.ajog.2012.08.011. Epub 2012 Aug 10.
5
A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer.土耳其妇科肿瘤学组对早期子宫内膜癌的保留生育力治疗的研究。
Int J Gynaecol Obstet. 2012 Dec;119(3):270-3. doi: 10.1016/j.ijgo.2012.06.010. Epub 2012 Aug 24.
6
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征女性的超重、肥胖和中心性肥胖：系统评价和荟萃分析。
Hum Reprod Update. 2012 Nov-Dec;18(6):618-37. doi: 10.1093/humupd/dms030. Epub 2012 Jul 4.
7
Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis.宫腔镜检查对子宫内膜癌细胞腹膜播散的影响：一项荟萃分析。
Fertil Steril. 2011 Oct;96(4):957-61. doi: 10.1016/j.fertnstert.2011.07.1146. Epub 2011 Aug 26.
8
Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials.选择性单胚胎移植与双胚胎移植的临床效果：来自随机试验的个体患者数据的荟萃分析。
BMJ. 2010 Dec 21;341:c6945. doi: 10.1136/bmj.c6945.
9
Conservative treatment of early endometrial cancer: preliminary results of a pilot study.早期子宫内膜癌的保守治疗：一项初步研究的结果。
Gynecol Oncol. 2011 Jan;120(1):43-6. doi: 10.1016/j.ygyno.2010.10.004. Epub 2010 Oct 30.
10
Conservative surgical management of stage IA endometrial carcinoma for fertility preservation.保留生育力前提下的 IA 期子宫内膜癌的保守手术治疗。
Fertil Steril. 2010 Mar 1;93(4):1286-9. doi: 10.1016/j.fertnstert.2008.12.009. Epub 2009 Aug 22.
Zotero 插件